• Specialists in assisting
    people with access to the
    important therapy of FMT
  • Specialists in assisting
    people with access to the
    important therapy of FMT
The Clinic
The Melbourne FMT Clinic and the Centre For Irritable Bowel Solutions were both founded by Dr Paul Froomes as part of his private gastroenterology clinic.
Read more
Fecal Microbiota Transplant (FMT) is a procedure in which faecal matter, or stool, is collected from a tested donor and placed in a patient, by colonoscopy, endoscopy, sigmoidoscopy, or enema.
Read more
The booking deposit is $1,000 (AUD) which holds your place on a program. Please see our terms and conditions in the online brochure.
Read more
These FAQs are expressly not to be interpreted as instructions for home treatments. The Melbourne FMT Clinic will not accept responsibility for any outcomes howsoever caused from anyone using these FAQs
Read more

Welcome to The Melbourne FMT Clinic

The Melbourne FMT Clinic is a specialist centre assisting people with access to the important therapy of Faecal Microbial Transplant. We specialise in the production of screened, high quality gut bacteria and effective, efficient FMT implant techniques. Researching intestinal bacteria since 2006, the Melbourne FMT Clinic has been a key provider of Faecal Microbiota Transplant (FMT) procedures to create a “normal”bacterial environment in patients with a broad range of conditions since 2013. 


If you would like to know more about this therapy and how it might help you please call us on 03 9331 3122 or email at danielle@drpaulfroomes.com.au.


The concept of faecal microbial transplant has come a long way in the last decade. We have found that doctors & hospitals in Australia and overseas are taking an increased interest in FMT just as mainstream media has and the hope is that it will become more accessible for the people who need it.


We find more and more research every day that shows that our gut microbiota have more of an impact on our health than we previously thought so it is likely that FMT will be used to treat a wider variety of conditions over the next few years.


‘Faecal microbiota transplantation (FMT), or infusion of a faecal suspension from a healthy individual into the gastrointestinal (GI) tract of another person to cure a specific disease, is best known as a treatment for recurrent Clostridium difficile infection (RCDI); FMT, however, also has been used successfully for inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), idiopathic constipation and a variety of non-GI diseases.


Recent studies have shown that the intestinal microbiota plays an important role in immunity and energy metabolism and that an imbalance in our commensal intestinal bacteria can predispose to disease development.[1] Re-establishment of the wide diversity of intestinal microbiota via infusion of donor feces into the colon is the proposed mechanism by which FMT results in clinical improvement in patients with RCDI.


FMT is by no means a new therapeutic modality, however, it did not receive public attention until recently, after several studies were published showing that stool is a biologically active, complex mixture of living organisms with great therapeutic potential for Clostridium difficile infection (CDI)[2–4] and perhaps other GI[5–8] and non-GI disorders.


[9,10] The revelations about the human microbiome being published by the Human Microbiome Project consortium is bringing the strength of science to clinical observation, thereby enhancing our understanding of the complexities of our intestine and stool.’ 


For an up to date review of FMT please read the following papers:

Melbourne FMT


Excerpt taken from Aroniadis O & Brandt L. Fecal Microbiota Transplantation Past, Present and Future. Curr Opin Gastroenterol. 2013;29(1):79-84.





1. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2011; 9:88–96.


2. Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44:551–561.


3. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ.Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile associated diarrhea. J Clin Gastroenterol 2010; 44:354– 360.

4. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197:435–438.

5. Borody TJ, Warren EF, Leis SM, et al. Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 2004; 38:475–483.

6. Borody TJ, George L, Andrews PJ, et al. Bowel flora alteration: a potential cure of inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989; 150:604.

7. Borody TJ, Leis S, McGrath K, et al. Treatment of chronic constipation and colitis using human probiotic infusions: In: Probiotics, prebiotics and new foods conference, Universita Urbaniana, Rome, September 2–4, 2001.

8. Borody TJ, Warrne EF, Leis S, et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37:42–47.

9. Vrieze A, van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in subjects with metabolic syndrome. Gastroenterology 2012 [Epub ahead of print].

10. AnathaswamyA.Faecal transplant eases symptoms of Parkinson’s. NewScientist 2011;2796:8–9.